Details for Patent: 7,820,681
✉ Email this page to a colleague
Which drugs does patent 7,820,681 protect, and when does it expire?
Patent 7,820,681 protects COLCRYS and is included in one NDA.
Summary for Patent: 7,820,681
Title: | Methods for concomitant administration of colchicine and a second active agent |
Abstract: | Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided. |
Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
Application Number: | 12/372,046 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,820,681 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,820,681
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |